105 related articles for article (PubMed ID: 31982616)
1. Nanostructured lipid carriers accumulate in atherosclerotic plaques of ApoE
Vigne J; Cabella C; Dézsi L; Rustique E; Couffin AC; Aid R; Anizan N; Chauvierre C; Letourneur D; Le Guludec D; Rouzet F; Hyafil F; Mészáros T; Fülöp T; Szebeni J; Cordaro A; Oliva P; Mourier V; Texier I
Nanomedicine; 2020 Apr; 25():102157. PubMed ID: 31982616
[TBL] [Abstract][Full Text] [Related]
2. Biodistribution of Nanostructured Lipid Carriers in Mice Atherosclerotic Model.
Devel L; Almer G; Cabella C; Beau F; Bernes M; Oliva P; Navarro F; Prassl R; Mangge H; Texier I
Molecules; 2019 Sep; 24(19):. PubMed ID: 31561608
[TBL] [Abstract][Full Text] [Related]
3. Deletion of the angiotensin II type 1a receptor prevents atherosclerotic plaque rupture in apolipoprotein E-/- mice.
Aono J; Suzuki J; Iwai M; Horiuchi M; Nagai T; Nishimura K; Inoue K; Ogimoto A; Okayama H; Higaki J
Arterioscler Thromb Vasc Biol; 2012 Jun; 32(6):1453-9. PubMed ID: 22460554
[TBL] [Abstract][Full Text] [Related]
4. Practical assessment of the quantification of atherosclerotic lesions in apoE⁻/⁻ mice.
Lin Y; Bai L; Chen Y; Zhu N; Bai Y; Li Q; Zhao S; Fan J; Liu E
Mol Med Rep; 2015 Oct; 12(4):5298-306. PubMed ID: 26239265
[TBL] [Abstract][Full Text] [Related]
5. Perilipin1 deficiency in whole body or bone marrow-derived cells attenuates lesions in atherosclerosis-prone mice.
Zhao X; Gao M; He J; Zou L; Lyu Y; Zhang L; Geng B; Liu G; Xu G
PLoS One; 2015; 10(4):e0123738. PubMed ID: 25855981
[TBL] [Abstract][Full Text] [Related]
6. Deletion of the Mir-106b~ 25 MicroRNA cluster attenuates atherosclerosis in Apolipoprotein E knockout mice.
Semo J; Chernin G; Jonas M; Shimoni S; George J
Lipids Health Dis; 2019 Dec; 18(1):208. PubMed ID: 31796057
[TBL] [Abstract][Full Text] [Related]
7. The fat-fed apolipoprotein E knockout mouse brachiocephalic artery in the study of atherosclerotic plaque rupture.
Bond AR; Jackson CL
J Biomed Biotechnol; 2011; 2011():379069. PubMed ID: 21076539
[TBL] [Abstract][Full Text] [Related]
8. Altered Clock and Lipid Metabolism-Related Genes in Atherosclerotic Mice Kept with Abnormal Lighting Condition.
Zhu Z; Hua B; Shang Z; Yuan G; Xu L; Li E; Li X; Sun N; Yan Z; Qian R; Lu C
Biomed Res Int; 2016; 2016():5438589. PubMed ID: 27631008
[TBL] [Abstract][Full Text] [Related]
9. Detection of early stage atherosclerotic plaques using PET and CT fusion imaging targeting P-selectin in low density lipoprotein receptor-deficient mice.
Nakamura I; Hasegawa K; Wada Y; Hirase T; Node K; Watanabe Y
Biochem Biophys Res Commun; 2013 Mar; 433(1):47-51. PubMed ID: 23485468
[TBL] [Abstract][Full Text] [Related]
10. Preclinical evaluation of an
Park JY; Kim HJ; Chae JR; Cho YL; Kang WJ
Biochem Biophys Res Commun; 2024 Apr; 703():149650. PubMed ID: 38377941
[TBL] [Abstract][Full Text] [Related]
11. Platelet membrane-coated nanoparticle-mediated targeting delivery of Rapamycin blocks atherosclerotic plaque development and stabilizes plaque in apolipoprotein E-deficient (ApoE
Song Y; Huang Z; Liu X; Pang Z; Chen J; Yang H; Zhang N; Cao Z; Liu M; Cao J; Li C; Yang X; Gong H; Qian J; Ge J
Nanomedicine; 2019 Jan; 15(1):13-24. PubMed ID: 30171903
[TBL] [Abstract][Full Text] [Related]
12. Combination of tanshinone IIA and astragaloside IV attenuate atherosclerotic plaque vulnerability in ApoE(-/-) mice by activating PI3K/AKT signaling and suppressing TRL4/NF-κB signaling.
Wang N; Zhang X; Ma Z; Niu J; Ma S; Wenjie W; Chen J
Biomed Pharmacother; 2020 Mar; 123():109729. PubMed ID: 31887543
[TBL] [Abstract][Full Text] [Related]
13. Comparative lipid profiling of murine and human atherosclerotic plaques using high-resolution MALDI MSI.
Khamehgir-Silz P; Gerbig S; Volk N; Schulz S; Spengler B; Hecker M; Wagner AH
Pflugers Arch; 2022 Feb; 474(2):231-242. PubMed ID: 34797426
[TBL] [Abstract][Full Text] [Related]
14. CCR5 facilitates endothelial progenitor cell recruitment and promotes the stabilization of atherosclerotic plaques in ApoE-/- mice.
Zhang Z; Dong J; Lobe CG; Gong P; Liu J; Liao L
Stem Cell Res Ther; 2015 Mar; 6(1):36. PubMed ID: 25889019
[TBL] [Abstract][Full Text] [Related]
15. EphA2 knockdown attenuates atherosclerotic lesion development in ApoE(-/-) mice.
Jiang H; Li X; Zhang X; Liu Y; Huang S; Wang X
Cardiovasc Pathol; 2014; 23(3):169-74. PubMed ID: 24561077
[TBL] [Abstract][Full Text] [Related]
16. Tollip Deficiency Alters Atherosclerosis and Steatosis by Disrupting Lipophagy.
Chen K; Yuan R; Zhang Y; Geng S; Li L
J Am Heart Assoc; 2017 Apr; 6(4):. PubMed ID: 28396568
[TBL] [Abstract][Full Text] [Related]
17. Targeting Coagulation Factor Xa Promotes Regression of Advanced Atherosclerosis in Apolipoprotein-E Deficient Mice.
Posthuma JJ; Posma JJN; van Oerle R; Leenders P; van Gorp RH; Jaminon AMG; Mackman N; Heitmeier S; Schurgers LJ; Ten Cate H; Spronk HMH
Sci Rep; 2019 Mar; 9(1):3909. PubMed ID: 30846818
[TBL] [Abstract][Full Text] [Related]
18. α4β7 Integrin (LPAM-1) is upregulated at atherosclerotic lesions and is involved in atherosclerosis progression.
Zhi K; Li M; Zhang X; Gao Z; Bai J; Wu Y; Zhou S; Li M; Qu L
Cell Physiol Biochem; 2014; 33(6):1876-87. PubMed ID: 24970009
[TBL] [Abstract][Full Text] [Related]
19. Attenuated atherogenesis in apolipoprotein E-deficient mice lacking amyloid precursor protein.
Van De Parre TJ; Guns PJ; Fransen P; Martinet W; Bult H; Herman AG; De Meyer GR
Atherosclerosis; 2011 May; 216(1):54-8. PubMed ID: 21316678
[TBL] [Abstract][Full Text] [Related]
20. Simvastatin suppresses apoptosis in vulnerable atherosclerotic plaques through regulating the expression of p(53), Bcl-2 and Bcl-xL.
Qin W; Lu Y; Zhan C; Shen T; Dou L; Man Y; Wang S; Xiao C; Bian Y; Li J
Cardiovasc Drugs Ther; 2012 Feb; 26(1):23-30. PubMed ID: 22038096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
